Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Reddys Laboratories | Q1 FY26 Different companies are betting on different geographies
As of 2026, over 50% of the patents surrounding the GLP-1 franchise cover the mechanical injector devices, with protections extending between 2032 and 2038
Certain patientssuch as those with specific types of endocrine cancersshould avoid GLP1s, he explained, and there are clear guidelines for who may benefit most, including people with diabetes, obesity or other chronic conditions that contribute to long-term weight gain
She tried to contact her doctor, but when she didnt get an immediate response, she said she called the company and a care team representative confirmed the instructionswhich said to inject 2.21 milligrams of the semaglutide medication once a weekwere correct
However, the evidence against them remains strong, particularly regarding the companies' failure to disclose severe gastrointestinal risks
